drugset / Trial / NCT05133752
Oral Nemonoxacin in Treating Elderly Patients With CAP
NaSingle-groupOpen-labelTreatment
Summary
This study was to evaluate the safety and efficacy of oral nemonoxacin in treating elderly patients (aged ≥ 65 years) with community-acquired pneumonia (CAP).
Timeline
- Start
- 2018-09-11
- Primary completion
- 2020-03-23
- Completion
- 2020-03-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nemonoxacin | Small molecule | 500 mg | Oral |